Laura Sutcliffe
Stock Analyst at UBS
(1.26)
# 1613
Out of 5,327 analysts
8
Total ratings
60.00%
Success rate
15.84%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
RMD ResMed | Maintains: Buy | 290 285 | 237.74 | 19.88% | 1 | Apr 24, 2025 | |
TLX Telix Pharmaceutical... | Maintains: Strong Buy | 21 22 | 17.41 | 26.36% | 2 | Jan 27, 2025 | |
UCBJY UCB | Upgrades: Buy | n/a | n/a | n/a | 1 | Aug 23, 2021 | |
ARGX argenx | Initiates Coverage On: Buy | 390 | 629.84 | -38.08% | 1 | Jun 18, 2021 | |
GNHAF Vifor Pharma AG | Upgrades: Neutral | n/a | n/a | n/a | 1 | Mar 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Dec 20, 2019 |